![Jeppe Øvlesen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeppe Øvlesen
Fondateur chez
SYNACT PHARMA AB
Fortune : 710 172 $ au 31/05/2026
Profil
Jeppe Øvli Øvlesen was the founder of ChemoMetec A, founded in 1998, where the title held was Chief Executive & Financial Officer from 1998 to 2003.
Mr. Øvlesen was the founder of Getinge Cetrea A, founded in 2007, with the title Director from 2007 to 2012.
Mr. Øvlesen was the founder of Mindway AI ApS, founded in 2018, serving as Chairman & Chief Executive Officer from 2018 to 2019.
Mr. Øvlesen is the founder of SynAct Pharma AB, founded in 2024, currently holding the titles Chief Executive Officer & Director since 2024.
Mr. Øvlesen is also the founder of QIAGEN Aarhus A,PNN Medical A,TXP Pharma GmbH..
Mr. Øvlesen is currently Chairman at Vikarbasen A since 2009, Chairman at Neurescue ApS since 2020, Chairman at Go-Pen ApS, Chairman at Cereno Scientific AB starting 2025, Chairman at Cercare Medical A, Director at Enovacor ApS since 2013, Director at Sundialog A, Director at ResoTher Pharma AS since 2018, Director at Perfusion Tech ApS since 2017, and Member-Executive Board at Corporate Culture ApS since 2014.
Former positions include Chief Executive Officer at PNN Medical SA, Chief Executive Officer at SynAct Pharma AB from 2014 to 2023, Chief Executive Officer at Cercare Medical A from 2017 to 2020, Director at NordEnergie Renewables A from 2005 to 2013, Director at Vintage Cloud A from 2015 to 2019, Independent Director at Monsenso A, Director at CPHI-Holding A from 2016 to 2018, Director at ACT.Global A in 2018, Chief Financial Officer & VP-Business Development at Action Pharma A from 2009 to 2011, Member-Executive Board at Vingmed Danmark A from 2015 to 2018, and Member-Executive Board at Quantass ApS from 2013 to 2020.
Education includes an MBA degree from the University of Hartford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNACT PHARMA AB 0,66% | 17/12/2025 | 350 265 ( 0,66% ) | 660 831 $ | 31/05/2026 |
| 31/12/2024 | 85 234 ( 0,03% ) | 49 341 $ | 31/05/2026 |
Postes actifs de Jeppe Øvlesen
| Sociétés | Poste | Début |
|---|---|---|
| SYNACT PHARMA AB | Fondateur | - |
| CERENO SCIENTIFIC AB | Président | 10/06/2025 |
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Provides automated identification of viable tissue in acute stroke | Président | - |
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Develops insulin pen | Président | - |
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Provides medical devices for the treatment of cardiac arrest | Président | 01/03/2020 |
Perfusion Tech ApS | Directeur/Membre du Conseil | 25/10/2017 |
Corporate Culture ApS | Corporate Officer/Principal | 30/06/2014 |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Directeur/Membre du Conseil | 11/07/2018 |
Sundialog A/S | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Jeppe Øvlesen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeppe Øvlesen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
ChemoMetec A/S
 ChemoMetec A/S Medical SpecialtiesHealth Technology Develops, manufactures and sells analytical equipment for the enumeration of cells in fluids | Health Technology |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services Provides software and hardware solutions for bioinformatics | Technology Services |
Getinge Cetrea A/S
 Getinge Cetrea A/S Packaged SoftwareTechnology Services Develops clinical logistics and communication software products | Technology Services |
NordEnergie Renewables A/S
 NordEnergie Renewables A/S Electric UtilitiesUtilities Provides and operates wind parks and supplies renewable energy | Utilities |
PNN Medical A/S | |
Vingmed Danmark A/S | |
Enovacor ApS | |
Vikarbasen A/S | |
PNN Medical SA | |
Sundialog A/S | |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
Cercare Medical A/S
Cercare Medical A/S Packaged SoftwareTechnology Services Provides automated identification of viable tissue in acute stroke | Technology Services |
Neurescue ApS
Neurescue ApS Medical SpecialtiesHealth Technology Provides medical devices for the treatment of cardiac arrest | Health Technology |
TXP Pharma GmbH | |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Vintage Cloud A/S
 Vintage Cloud A/S Electronics DistributorsDistribution Services Engages in the wholesale of computers, peripherals, and software | Distribution Services |
Corporate Culture ApS | |
Monsenso A/S
 Monsenso A/S Internet Software/ServicesTechnology Services Provides mobile health solutions for mental health can help in the prevention, early intervention and treatment of mental illness or behavioral disorders | Technology Services |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Health Technology |
Quantass ApS | |
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Develops technology solutions for identification of at-risk gambling | Technology Services |
CPHI-Holding A/S
 CPHI-Holding A/S Miscellaneous Commercial ServicesCommercial Services Provides industrial, product, communication and graphic design services | Commercial Services |
ACT.Global A/S
 ACT.Global A/S Industrial MachineryProducer Manufacturing Manufactures air purification equipment | Producer Manufacturing |
Perfusion Tech ApS | |
Go-PEN Aps
Go-PEN Aps Medical SpecialtiesHealth Technology Develops insulin pen | Health Technology |
